annual operating expenses:
$671.77M+$291.28M(+76.55%)Summary
- As of today (June 2, 2025), MDGL annual total operating expenses is $671.77 million, with the most recent change of +$291.28 million (+76.55%) on December 31, 2024.
- During the last 3 years, MDGL annual operating expenses has risen by +$429.29 million (+177.04%).
- MDGL annual operating expenses is now at all-time high.
Performance
MDGL Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$212.05M+$45.18M(+27.07%)Summary
- As of today (June 2, 2025), MDGL quarterly total operating expenses is $212.05 million, with the most recent change of +$45.18 million (+27.07%) on March 31, 2025.
- Over the past year, MDGL quarterly operating expenses has increased by +$60.01 million (+39.47%).
- MDGL quarterly operating expenses is now at all-time high.
Performance
MDGL quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MDGL Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +76.5% | +39.5% |
| 3 y3 years | +177.0% | +268.2% |
| 5 y5 years | +607.3% | +457.9% |
MDGL Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +177.0% | at high | +268.2% |
| 5 y | 5-year | at high | +607.3% | at high | +457.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
MDGL Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $212.05M(+27.1%) |
| Dec 2024 | $671.77M(+76.6%) | $166.87M(-5.4%) |
| Sep 2024 | - | $176.33M(-0.1%) |
| Jun 2024 | - | $176.54M(+16.1%) |
| Mar 2024 | - | $152.04M(+29.8%) |
| Dec 2023 | $380.50M(+29.6%) | $117.18M(+18.9%) |
| Sep 2023 | - | $98.53M(+14.0%) |
| Jun 2023 | - | $86.45M(+10.4%) |
| Mar 2023 | - | $78.34M(-8.2%) |
| Dec 2022 | $293.57M(+21.1%) | $85.30M(+6.1%) |
| Sep 2022 | - | $80.41M(+14.4%) |
| Jun 2022 | - | $70.27M(+22.0%) |
| Mar 2022 | - | $57.59M(-10.9%) |
| Dec 2021 | $242.48M(+17.3%) | $64.60M(+2.3%) |
| Sep 2021 | - | $63.16M(+2.3%) |
| Jun 2021 | - | $61.74M(+16.5%) |
| Mar 2021 | - | $52.98M(-11.0%) |
| Dec 2020 | $206.67M(+117.6%) | $59.55M(+1.3%) |
| Sep 2020 | - | $58.79M(+16.8%) |
| Jun 2020 | - | $50.33M(+32.4%) |
| Mar 2020 | - | $38.01M(+26.9%) |
| Dec 2019 | $94.97M(+133.4%) | $29.95M(+23.8%) |
| Sep 2019 | - | $24.20M(+6.6%) |
| Jun 2019 | - | $22.70M(+25.3%) |
| Mar 2019 | - | $18.12M(+25.4%) |
| Dec 2018 | $40.68M(+26.9%) | $14.45M(+27.5%) |
| Sep 2018 | - | $11.33M(+44.8%) |
| Jun 2018 | - | $7.83M(+10.7%) |
| Mar 2018 | - | $7.07M(-20.7%) |
| Dec 2017 | $32.06M(+27.1%) | $8.91M(+3.2%) |
| Sep 2017 | - | $8.64M(+2.3%) |
| Jun 2017 | - | $8.44M(+38.9%) |
| Mar 2017 | - | $6.08M(-21.7%) |
| Dec 2016 | $25.22M(+680.2%) | $7.75M(-45.0%) |
| Sep 2016 | - | $14.09M(+434.0%) |
| Jun 2016 | - | $2.64M(+257.6%) |
| Mar 2016 | - | $738.00K(-19.6%) |
| Dec 2015 | $3.23M(-96.1%) | $918.40K(+4.4%) |
| Sep 2015 | - | $880.00K(-95.5%) |
| Jun 2015 | - | $19.50M(-4.1%) |
| Mar 2015 | - | $20.33M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $83.95M(-4.1%) | $19.89M(+2.3%) |
| Sep 2014 | - | $19.45M(-10.4%) |
| Jun 2014 | - | $21.70M(-5.3%) |
| Mar 2014 | - | $22.91M(-2.3%) |
| Dec 2013 | $87.56M(+43.3%) | $23.44M(+7.6%) |
| Sep 2013 | - | $21.79M(-1.2%) |
| Jun 2013 | - | $22.06M(+8.9%) |
| Mar 2013 | - | $20.26M(+14.4%) |
| Dec 2012 | $61.09M(+15.2%) | $17.70M(+21.8%) |
| Sep 2012 | - | $14.54M(+2.9%) |
| Jun 2012 | - | $14.13M(-3.9%) |
| Mar 2012 | - | $14.71M(+7.7%) |
| Dec 2011 | $53.02M(+2.5%) | $13.66M(-1.6%) |
| Sep 2011 | - | $13.88M(+3.9%) |
| Jun 2011 | - | $13.36M(+10.4%) |
| Mar 2011 | - | $12.11M(-2.4%) |
| Dec 2010 | $51.70M(-18.8%) | $12.40M(-8.9%) |
| Sep 2010 | - | $13.61M(+9.8%) |
| Jun 2010 | - | $12.40M(-6.6%) |
| Mar 2010 | - | $13.28M(+13.9%) |
| Dec 2009 | $63.70M(-33.9%) | $11.66M(-4.7%) |
| Sep 2009 | - | $12.23M(-6.6%) |
| Jun 2009 | - | $13.10M(-50.9%) |
| Mar 2009 | - | $26.71M(+0.8%) |
| Dec 2008 | $96.32M(+43.9%) | $26.50M(-4.4%) |
| Sep 2008 | - | $27.72M(+24.2%) |
| Jun 2008 | - | $22.32M(+12.8%) |
| Mar 2008 | - | $19.78M(+15.8%) |
| Dec 2007 | $66.96M(+13.2%) | $17.09M(+11.0%) |
| Sep 2007 | - | $15.39M(-11.9%) |
| Jun 2007 | - | $17.47M(+2.7%) |
| Mar 2007 | - | $17.01M(+30.8%) |
| Dec 2006 | $59.15M(-16.9%) | $13.01M(-10.8%) |
| Sep 2006 | - | $14.58M(-21.2%) |
| Dec 2005 | $71.18M(+56.4%) | - |
| Mar 2005 | - | $18.50M(+228.9%) |
| Dec 2004 | $45.52M(+53.8%) | - |
| Mar 2004 | - | $5.63M |
| Dec 2003 | $29.60M(+305.9%) | - |
| Dec 2002 | $7.29M(+1718.5%) | - |
| Dec 2001 | $401.00K | - |
FAQ
- What is Madrigal Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual operating expenses year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly operating expenses year-on-year change?
What is Madrigal Pharmaceuticals annual total operating expenses?
The current annual operating expenses of MDGL is $671.77M
What is the all time high annual operating expenses for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total operating expenses is $671.77M
What is Madrigal Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, MDGL annual total operating expenses has changed by +$291.28M (+76.55%)
What is Madrigal Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of MDGL is $212.05M
What is the all time high quarterly operating expenses for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total operating expenses is $212.05M
What is Madrigal Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, MDGL quarterly total operating expenses has changed by +$60.01M (+39.47%)